JUSTIN COLE: Open Payments
NPI 1588053052 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,772 in 125 payments from 31 companies in 2025. Trend: 2023 $2,938 · 2024 $3,315 · 2025 $2,772
Food & beverage: $2,772
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $280 |
| ABBVIE INC. | 17 | $245 |
| ARGENX US, INC. | 9 | $213 |
| Biogen, Inc. | 9 | $192 |
| ANI Pharmaceuticals, Inc. | 8 | $183 |
| ACADIA Pharmaceuticals Inc | 7 | $162 |
| Axsome Therapeutics, Inc. | 2 | $138 |
| Lundbeck LLC | 6 | $135 |
| JAZZ PHARMACEUTICALS INC. | 6 | $135 |
| PFIZER INC. | 7 | $131 |
Products named: VYVGART HYTRULO, Briviact, PURIFIED CORTROPHIN GEL, NUPLAZID, Symbravo, EPIDIOLEX, REXULTI, UBRELVY.
Industry payments across MS — which companies pay providers there.
